Michael Hunt, CFO at ReNeuron Group Plc (LON:RENE) tells Proactive positive long-term data on their CTX cell therapy for stroke has been presented at the American Heart Association International Stroke Conference in Los Angeles.
Professor Keith Muir, of the Queen Elizabeth University Hospital, Glasgow and Principal Investigator for ReNeuron's PISCES II study, told the audience that upper limb functional recovery was "durable and maintained" out to 12 months post-treatment.
Meet Reward Minerals Ltd, Recce Ltd, Rimfire Pacific Mining NL and Aus Tin Mining at our event, Melbourne, 31 January 2018.Register here >>